-+ 0.00%
-+ 0.00%
-+ 0.00%

Mira Pharmaceuticals Initiates Dosing Final Group Of Its Phase 1 Multiple Ascending Dose Clinical Study Of Ketamir-2

Benzinga·02/02/2026 21:04:42
Listen to the news

SEC Filing.